First deployment of robotic bronchoscopy in KoreaSouth Korea’s National Cancer Center is set to introduce robotic-assisted endoscopic imaging for lung cancer diagnosis.
This is a Korea-first deployment of the robotic bronchoscopy platform by United States-based…
Population-wide cancer screening programs in Germany have tapped support from South Korean medical imaging AI providers.KOSDAQ-listed Lunit recently signed a five-year partnership with private radiology network Starvision Service to deploy several medical imaging AI…
Continue Reading
An AI-powered lung cancer screening analysis software by South Korean company Coreline Soft has been added to the medical AI platform of global pharmaceutical firm Bayer. Its flagship product, AVIEW LCS, is now among the selections of…
Continue Reading
Peninsula Imaging Network (PenRAD) has launched an AI-powered chest CT service across four NHS trusts in Devon, Cornwall and the Isles of Scilly to help detect lung cancer quicker.
Qure.ai’s AI for chest CT (qCT)…
What You Should Know:
– University Hospitals Cleveland Medical Center (UH) has announced a groundbreaking collaboration with global healthcare Artificial Intelligence (AI) innovator Qure.ai to deploy chest X-ray AI supporting earlier identification of lung cancers.
– The…
Continue Reading
Background: Lung cancer ranks as the leading cause of cancer-related deaths. For lung cancer survivors, cardiopulmonary fitness is a strong independent predictor of survival, while surgical interventions impact both cardiovascular and pulmonary function. Home-based…
Continue Reading
Coreline Soft announces Australia launch, new FDA approvalSouth Korean medical imaging AI company Coreline Soft has made its way to Australia after securing a partnership with a major medical device supplier.
It entered into a…
What You Should Know:
– Oatmeal Health, an innovator in AI-driven cancer screening launches its AI-powered radiology risk stratification platform for lung cancer.
– The solution provides a fully reimbursable second-opinion diagnostic tool covered by Medicare,…
Continue Reading
Simon Rasalingham, chief executive of Behold.ai (Credit: Prix Galien International)
UK-based digital health start-up Behold.ai has entered administration after failing to win any contracts under the government’s AI Diagnostic Fund.
Behold.ai supplies lung cancer AI…
In this interview, Dr. Samir Shah, Chief Medical Officer at Qure.ai, shares why achieving FDA approval is crucial for their AI solutions and for fostering trust in the technology. Dr. Shah discusses how their…
Continue Reading
